These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21474126)

  • 1. Hormone-induced delayed ovulation affects early embryonic development.
    Bittner AK; Horsthemke B; Winterhager E; Grümmer R
    Fertil Steril; 2011 Jun; 95(7):2390-4. PubMed ID: 21474126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of embryo implantation in Wistar rats that underwent ovarian stimulation using exogenous gonadotropins associated with cetrorelix acetate or leuprolide acetate.
    Torres Mde M; Donadio N; Donadio NF; Brandão AC; Heck B
    Fertil Steril; 2005 Oct; 84 Suppl 2():1235-40. PubMed ID: 16210016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction.
    Bukulmez O; Carr BR; Doody KM; Doody KJ
    Fertil Steril; 2008 Jan; 89(1):74-83. PubMed ID: 17662281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.
    Tur-Kaspa I; Ezcurra D
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1323-36. PubMed ID: 19761413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase: A Randomized Controlled Trial.
    Maged AM; Nada AM; Abohamila F; Hashem AT; Mostafa WA; Elzayat AR
    Reprod Sci; 2015 Dec; 22(12):1627-31. PubMed ID: 26045549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
    Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
    Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
    D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
    Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a hamster superovulation program and adverse effects of gonadotropins on microfilament formation during oocyte development.
    Lee ST; Kim TM; Cho MY; Moon SY; Han JY; Lim JM
    Fertil Steril; 2005 Apr; 83 Suppl 1():1264-74. PubMed ID: 15831301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the gonadotropin-releasing hormone antagonist cetrorelix in the early postimplantation period on rat pregnancy.
    Tug N; Uslu U; Cumbul A; Eyuboglu S; Cam C; Karateke A; Yilmaz B
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):166-70. PubMed ID: 21242023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetrorelix in women with poor ovarian response in previous assisted reproduction cycles.
    Brook N; Lavery S; Margara R; Trew G
    J Obstet Gynaecol; 2006 Apr; 26(3):236-40. PubMed ID: 16698632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.
    Lee TH; Wu MY; Chen HF; Chen MJ; Ho HN; Yang YS
    Fertil Steril; 2005 Jun; 83(6):1700-7. PubMed ID: 15950639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model.
    Foster R; Segers I; Smart D; Adriaenssens T; Smitz J; Arce JC; Princivalle M
    Fertil Steril; 2010 Mar; 93(5):1464-76. PubMed ID: 19362302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal induction of ovulation stimulates atresia of antral follicles in a vespertilionid bat, Scotophilus heathi.
    Chanda D; Abhilasha ; Krishna A
    Zoology (Jena); 2006; 109(3):208-16. PubMed ID: 16814533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of visfatin during superovulation improves developmental competency of oocytes and fertility potential in aged female mice.
    Choi KH; Joo BS; Sun ST; Park MJ; Son JB; Joo JK; Lee KS
    Fertil Steril; 2012 May; 97(5):1234-41.e1-3. PubMed ID: 22425197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of GnRH agonists and antagonists in an ovular donation program].
    Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
    Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of human chorionic gonadotropin as a replacement for gonadotropin-releasing hormone in ovulation-synchronization protocols before fixed timed artificial insemination in beef cattle.
    Burns MG; Buttrey BS; Dobbins CA; Martel CA; Olson KC; Lamb GC; Stevenson JS
    J Anim Sci; 2008 Oct; 86(10):2539-48. PubMed ID: 18539821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.